Overview

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the effect of subcutaneous administration of immunoglobulin compared to intravenous treatment, for multifocal motor neuropathy NB. ONLY RECRUITING FROM DENMARK
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Aarhus
Treatments:
Antibodies
gamma-Globulins
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
Criteria
Inclusion Criteria:

- Clinical diagnosis of multifocal motor neuropathy, supported by electrophysiological
findings

Exclusion Criteria:

- Other severe medical conditions

- Pregnancy and lactation

- Anti-coagulation therapy